bipolar disorder

Latest Headlines

Latest Headlines

FDA expands indication of the only sublingual second-gen antipsychotic

The FDA has expanded the indication of Actavis's Saphris tablet, the only sublingual atypical, or second-generation, antipsychotic to include pediatric patients aged 10 to 17 with bipolar I disorder.

Smartphone app shows promise monitoring voice patterns to predict bipolar episodes

Caregivers typically step in after bipolar patients revert to a manic or depressive episode with a change in treatment or outright hospitalization. A University of Michigan research team said they've identified a biomarker that would allow intervention before those events even happen. They believe tracking changes in a patient's voice patterns, via a smartphone app, can help identify or even predict extreme mood swings.

Teva, Alexza launch inhaled schizophrenia, bipolar treatment in the U.S.

Teva Pharmaceutical Industries launched its Adasuve inhaled powder for the treatment of agitation associated with schizophrenia and bipolar I disorder in the U.S. The drug is the first of its kind with this delivery system, which uses Alexza Pharmaceuticals' Staccato device for absorption in the lungs.

Study: Left-handed people have higher rates of schizophrenia, other psychotic disorders

Your dominant hand may be an indicator of your predisposition to certain psychotic disorders, such as schizophrenia, according to a new study by Yale researchers.

Blood samples may aid suicide risk prediction

Scientists at the Indiana University School of Medicine said they've spotted 6 blood-based clues they believe could serve as viable predictors of suicide, led by the enzyme SAT1.

Gene variants increase bipolar risk

A collection of changes in genes linked with behavior could turn out to be pointers to the risk of bipolar disorder, according to research in the U.S.

Stem cells open new front against bipolar disorder

Heinz Prechter, founder of the American Sunroof Company, was a pioneering entrepreneur in Detroit's automotive industry--a vital community leader and philanthropist. But Prechter succumbed to a demon

Michigan develops iPS line for bipolar disorder; ESC still necessary

The Detroit Free Press reports on an iPS stem cell line developed by the University of Michigan that will enable researchers to study bipolar disorder. The report also splashes some cold water on

Biomarkers could give early warning of bipolar disorder

Bipolar disorder is a treatable disease, but it is often either misdiagnosed or not detected until too late--with sometimes devastating consequences. A research team that includes Michèle